AUTHOR=Molteni Laura , Rizzi Laura , Bresciani Elena , Possenti Roberta , Petrocchi Passeri Pamela , Ghè Corrado , Muccioli Giampiero , Fehrentz Jean-Alain , Verdié Pascal , Martinez Jean , Omeljaniuk Robert J. , Biagini Giuseppe , Binda Anna , Rivolta Ilaria , Locatelli Vittorio , Torsello Antonio TITLE=Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells JOURNAL=Frontiers in Pharmacology VOLUME=8 YEAR=2017 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00167 DOI=10.3389/fphar.2017.00167 ISSN=1663-9812 ABSTRACT=
VGF is a propeptide of 617 amino acids expressed throughout the central and the peripheral nervous system. VGF and peptides derived from its processing have been found in dense core vesicles and are released from neuronal and neuroendocrine cells via the regulated secretory pathway. Among VGF-derived neuropeptides, TLQP-21 (VGF556-576) has raised a huge interest and is one of most studied. TLQP-21 is a multifunctional neuropeptide involved in the control of several physiological functions, potentially including energy homeostasis, pain modulation, stress responsiveness and reproduction. Although little information is available about its receptor and the intracellular mechanisms mediating its biological effects, recent reports suggest that TLQP-21 may bind to the complement receptors C3aR1 and/or gC1qR. The first aim of this study was to ascertain the existence and nature of TLQP-21 binding sites in CHO cells. Secondly, we endeavored to characterize the ligand binding to these sites by using a small panel of VGF-derived peptides. And finally, we investigated the influence of TLQP-21 on selected intracellular signaling pathways. We report that CHO cells express a single class of saturable and specific binding sites for TLQP-21 with an affinity and capacity of